)
Edge3 Apr 2026
Extra Everything: The Story of Chipotle
Chipotle's story from a single restaurant to a nationwide chain, through crisis and turnaround, built on one of the strongest models in the industry.
Tenaya Therapeutics
Tenaya Therapeutics (TNYA) investor relations material
Tenaya Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary16 Apr, 2026
Executive summary
Annual meeting scheduled for May 27, 2026, to be held virtually for shareholders of record as of April 1, 2026.
Proxy materials, including the notice, proxy statement, and annual report, are available online, with paper copies available upon request.
Voting matters and shareholder proposals
Election of three Class II directors to serve until the 2029 annual meeting: Amy Burroughs, Karah Parschauer, and Catherine Stehman-Breen.
Ratification of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.
Amendment and restatement of the 2021 Equity Incentive Plan to increase reserved shares by approximately 3% of outstanding shares and remove the 4 million annual share limit from the evergreen provision.
Named proxies authorized to vote on additional business as may arise at the meeting.
Board of directors and corporate governance
Board recommends voting FOR all director nominees and both additional proposals.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Tenaya Therapeutics
- Shareholders will vote on director elections, auditor ratification, and an expanded equity plan.TNYA
Proxy filing16 Apr 2026 - Clinical progress, Alnylam deal, and financing extend cash runway into 2027.TNYAQ4 202511 Mar 2026
- Advancing gene therapies and small molecules, with new partnerships and pivotal data expected this year.TNYALeerink Global Healthcare Conference 20269 Mar 2026
- TN-201 phase 1b data expected H2; gene therapy targets large unmet needs in HCM and ARVC.TNYATD Cowen Genetic Medicines & RNA Summit3 Feb 2026
- Initial TN-201 gene therapy data for HCM expected this year, with broader updates in 2025.TNYAMorgan Stanley 22nd Annual Global Healthcare Conference22 Jan 2026
- TN-201 gene therapy shows early safety, robust cardiac delivery, and promising clinical signals.TNYAStudy Update11 Jan 2026
- Gene therapies for HCM and ARVC show strong early results, advancing toward pivotal trials.TNYACorporate Presentation9 Jan 2026
- Gene therapy programs for heart disease show early promise, with pivotal data expected in 2025-2026.TNYATD Cowen 45th Annual Healthcare Conference26 Dec 2025
- Gene therapy and small molecule programs advance toward key data and partnership milestones.TNYALeerink’s Global Healthcare Conference 202526 Dec 2025
Next Tenaya Therapeutics earnings date
Q1 20267 May, 2026
Tenaya Therapeutics
Next Tenaya Therapeutics earnings date
Q1 20267 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage